Compare INM & SSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INM | SSM |
|---|---|---|
| Founded | 1981 | 2016 |
| Country | Canada | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 6.4M |
| IPO Year | 2020 | 2021 |
| Metric | INM | SSM |
|---|---|---|
| Price | $1.35 | $2.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 52.7K | ★ 1.2M |
| Earning Date | 11-05-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.68 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,942,633.00 | N/A |
| Revenue This Year | N/A | $1,462,131.50 |
| Revenue Next Year | $26.00 | $48.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.58 | $1.05 |
| 52 Week High | $2.50 | $10.54 |
| Indicator | INM | SSM |
|---|---|---|
| Relative Strength Index (RSI) | 44.37 | 31.07 |
| Support Level | $1.25 | N/A |
| Resistance Level | $1.40 | $4.43 |
| Average True Range (ATR) | 0.06 | 0.25 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 35.28 | 4.17 |
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and services include Complete Solar Solutions, Solar Charge Controllers, Solar Modules, Data Services, and Engineering Services. The company's single business segment manages the financing, research and development, and product commercialization.